New modalities in hematopoietic stem cell transplant

被引：1

作者：

Dolores Caballero Barrigon, Maria ^{[1
]}

机构：

[1] Hosp Clin Univ, Serv Hematol & Hemoterapia, Unidad Clin Unidad Trasplante, Salamanca, Spain

来源：

MEDICINA CLINICA | 2009年 / 132卷 / 10期

关键词：

VERSUS-HOST-DISEASE; INTENSITY CONDITIONING REGIMENS; TOTAL-BODY IRRADIATION; UMBILICAL-CORD BLOOD; ACUTE-LEUKEMIA; BONE-MARROW; IMMUNOSUPPRESSION; CHEMOTHERAPY; EXPERIENCE; CHIMERISM;

D O I：

10.1016/j.medcli.2008.09.035

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：391 / 393

页数：3

共 23 条

[1] Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age [J].

Alyea, EP ;

Kim, HT ;

Ho, V ;

Cutler, C ;

Gribben, J ;

DeAngelo, DJ ;

Lee, SJ ;

Windawi, S ;

Ritz, J ;

Stone, RM ;

Antin, JH ;

Soiffer, RJ .

BLOOD, 2005, 105 (04) :1810-1814

[2] Haploidentical haematopoietic stem cell transplantation for acute leukaemia in adults: experience in Europe and the United States [J].

Aversa, F. .

BONE MARROW TRANSPLANTATION, 2008, 41 (05) :473-481

[3] Stem cell transplantation with reduced-intensity conditioning regimens: a review of ten years experience with new transplant concepts and new therapeutic agents [J].

Barrett, A. J. ;

Savani, B. N. .

LEUKEMIA, 2006, 20 (10) :1661-1672

[4] Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. [J].

Bensinger, WI ;

Martin, PJ ;

Storer, B ;

Clift, R ;

Forman, SJ ;

Negrin, R ;

Kashyap, A ;

Flowers, MED ;

Lilleby, K ;

Chauncey, TR ;

Storb, R ;

Appelbaum, FR ;

Rowley, S ;

Heimfeld, S ;

Blume, K .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (03) :175-181

[5] Umbilical cord blood transplantation: Basic biology and clinical challenges to immune reconstitution [J].

Brown, Julia A. ;

Boussiotis, Vassiliki A. .

CLINICAL IMMUNOLOGY, 2008, 127 (03) :286-297

[6] Allogeneic transplant with reduced intensity conditioning regimens may overcome the poor prognosis of B-cell chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene and chromosomal abnormalities (11q- and 17p-) [J].

Caballero, D ;

García-Macro, JA ;

Martino, R ;

Mateos, V ;

Ribera, JM ;

Sarrá, J ;

León, A ;

Sanz, G ;

la Serna, JC ;

Cabrera, R ;

González, M ;

Sierra, J ;

San Miguel, J .

CLINICAL CANCER RESEARCH, 2005, 11 (21) :7757-7763

[7] Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS [J].

de Lima, M ;

Couriel, D ;

Thall, PF ;

Wang, XM ;

Madden, T ;

Jones, R ;

Shpall, EJ ;

Shahjahan, M ;

Pierre, B ;

Giralt, S ;

Korbling, M ;

Russell, JA ;

Champlin, RE ;

Andersson, BS .

BLOOD, 2004, 104 (03) :857-864

[8]

FRASSONI F, 2008, LANCET ONCOL

[9] Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy [J].

Giralt, S ;

Estey, E ;

Albitar, M ;

vanBesien, K ;

Rondon, G ;

Anderlini, P ;

OBrien, S ;

Khouri, I ;

Gajewski, J ;

Mehra, R ;

Claxton, D ;

Andersson, B ;

Beran, M ;

Przepiorka, D ;

Koller, C ;

Kornblau, S ;

Korbling, M ;

Keating, M ;

Kantarjian, H ;

Champlin, R .

BLOOD, 1997, 89 (12) :4531-4536

[10] HEMATOPOIETIC RECONSTITUTION IN A PATIENT WITH FANCONIS ANEMIA BY MEANS OF UMBILICAL-CORD BLOOD FROM AN HLA-IDENTICAL SIBLING [J].

GLUCKMAN, E ;

BROXMEYER, HE ;

AUERBACH, AD ;

FRIEDMAN, HS ;

DOUGLAS, GW ;

DEVERGIE, A ;

ESPEROU, H ;

THIERRY, D ;

SOCIE, G ;

LEHN, P ;

COOPER, S ;

ENGLISH, D ;

KURTZBERG, J ;

BARD, J ;

BOYSE, EA .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (17) :1174-1178

← 1 2 3 →